OliX Pharmaceuticals, Inc (KOSDAQ: A226950)
Health Care · Biotechnology · KR
₩117,300.00
+0.43% today · +27.1% 1Y
OliX Pharmaceuticals, Inc (KOSDAQ: A226950) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.99B.
Over the last twelve months the share price has gained 27.1%, trading between 84.00K and 217.00K.
Tweenvest scores OliX Pharmaceuticals, Inc across four factors: quality 42/100, value 72/100, growth 100/100. Its strongest factor is growth.
A226950 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.99B
- Revenue (TTM)
- $8.81M
- P/E
- —
- EPS
- -662.79
- Dividend yield
- —
- Beta (5Y)
- 0.40
- 52-week high
- ₩217,000.00
- 52-week low
- ₩84,000.00
- Avg volume (3M)
- —
- Shares outstanding
- 22.75M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Wuhan Healthgen Biotechnology Corp.SHSE: 688765 | $2.02B | CN¥37.86 | -4.97% |
| Genus plcLSE: GNS | $2.02B | £22.80 | +2.61% |
| Palvella Therapeutics, Inc.NasdaqGM: PVLA | $2.00B | $138.77 | +4.76% |
| ABL Bio Inc.KOSDAQ: A298380 | $2.00B | ₩48,000.00 | -6.61% |
| Vir Biotechnology, Inc.NasdaqGS: VIR | $1.98B | $11.70 | +5.22% |
| Jinyu Bio-technology Co., Ltd.SHSE: 600201 | $1.93B | CN¥11.84 | +1.98% |
| Pell Bio-Med Technology Co., Ltd.TWSE: 6949 | $1.92B | NT$46.85 | +5.28% |
| Lakefront Biotherapeutics NVENXTAM: LKFT | $1.92B | €26.32 | +1.70% |
Figures last refreshed Oct 11, 2026.